<code id='982DA462C2'></code><style id='982DA462C2'></style>
    • <acronym id='982DA462C2'></acronym>
      <center id='982DA462C2'><center id='982DA462C2'><tfoot id='982DA462C2'></tfoot></center><abbr id='982DA462C2'><dir id='982DA462C2'><tfoot id='982DA462C2'></tfoot><noframes id='982DA462C2'>

    • <optgroup id='982DA462C2'><strike id='982DA462C2'><sup id='982DA462C2'></sup></strike><code id='982DA462C2'></code></optgroup>
        1. <b id='982DA462C2'><label id='982DA462C2'><select id='982DA462C2'><dt id='982DA462C2'><span id='982DA462C2'></span></dt></select></label></b><u id='982DA462C2'></u>
          <i id='982DA462C2'><strike id='982DA462C2'><tt id='982DA462C2'><pre id='982DA462C2'></pre></tt></strike></i>

          explore

          explore

          author:hotspot    Page View:9
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc
          Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

          INAFASSBENDER/AFPviaGettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup tog

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Illinois to ban advertising for guns allegedly marketed to kids and militants

          1:29FILE-Semi-automaticgunsaredisplayedforsaleatCapitolCityArmsSupply,Jan.16,2013,inSpringfield,Ill.